Skip to main content

Table 1 Mean values ± SD of bone architecture parameters in the femoral head, determined by means of μCT scanning analyses in rats after 4 months of treatment

From: The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

FEMORAL HEAD

SHAM (sham-operated controls)

(N = 10)

OVX (ovariectomized controls)

(N = 10)

WY OVX (ovariectomized, given Wyeth 14643)

(N = 9)

FENO OVX (ovariectomized, given fenofibrate)

(N = 10)

PIO OVX (ovariectomized, given pioglitazone)

(N = 9)

CORTICAL VOLUME

(Ct.V) (μm3)

31.98 ± 2.449

28.26 ± 1.491aa

28.59 ± 1.825 aa

27.71 ± 2.443 aaa

23.36 ± 1.578 aaa, bbb, ccc, ddd

CORTICAL THICKNESS

(Ct.Th) (μm)

449.4 ± 18.80

422.3 ± 21.21a

419.5 ± 19.64 aa

426.5 ± 18.48 a

372.7 ± 15.69 aaa, bbb, ccc, ddd

TRABECULAR BONE

VOLUME (BV) (μm3)

10.94 ± 1.365

10.69 ± 1.291

11.03 ± 1.176

10.25 ± 1.284

10.17 ± 1.468

TOTAL

VOLUME (TV) (μm3)

20.12 ± 2.062

23.70 ± 2.926 a

23.70 ± 2.926 aa

21.62 ± 1.737

26.52 ± 1.924 aaa, b, ccc, d

TRABECULAR

THICKNESS (Tb.Th) (μm)

155.2 ± 6.893

147.2 ± 3.445 a

146.2 ± 4.298 aa

150.6 ± 4.886

138.9 ± 6.828 aaa, b, ccc, d

CONNECTIVITY

DENSITY (CD) (1/mm3)

44.42 ± 9.160

46.34 ± 7.634

60.49 ± 20.60

47.26 ± 5.699

46.09 ± 5.317

STRUCTURE MODEL

INDEX (SMI) (0.0-3.0)

0.6509 ± 0.2211

0.9811 ± 0.1391 a

0.8556 ± 0.1588

0.9610 ± 0.1824 aa

1.179 ± 0.4074 aaa,d

TRABECULAR BONE

VOLUME FRACTION (BV/TV)

0.5436 ± 0.04273

0.4511 ± 0.02421 aaa

0.4700 ± 0.07018

0.4720 ± 0.03425 aa

0.3833 ± 0.05050 aaa, b, cc, d

  1. a, aa, aaa = p < 0.05, p < 0.01, p < 0.001 when compared to SHAM group
  2. b, bb, bbb = p < 0.05, p < 0.01, p < 0.001 when compared to OVX group
  3. c, cc, ccc = p < 0.05, p < 0.01, p < 0.001 when compared to FENO OVX group
  4. d, dd, ddd = p < 0.05, p < 0.01, p < 0.001 when compared to WY OVX group